Month: January 2022

Vertex’s Type I Diabetes Treatment: Pharmaceutical Moonshot
January 19, 2022 Blog Post Snowfish

Made famous in the tech industry, moonshots are ambition ventures with the promise of near-term profitability. In the pharmaceutical industry, Vertex Pharmaceuticals, known for its robust cystic fibrosis treatments (CF), is currently undertaking a moonshot of its own, the treatment of Type 1 Diabetes. Type 1 Diabetes afflicts 1.5 million Americans and requires a rigorous
Details

Telehealth Headed Into 2020
January 6, 2022 Blog Post Snowfish

With names such as BetterHelp, a sub company of Teladoc Health, interrupting your favorite podcasts, the post-pandemic era represents a critical tipping point for the adoption of telehealth. Prior to the recent pandemic, telemedicine radiological services was one of the few areas that had significant adoption.  The key issue was how to staff a small
Details

Stakeholders – The Long Game – Three Product Examples
January 5, 2022 Blog Post Snowfish

Every life science product exists within an ecosystem comprised of key stakeholders. Understanding and addressing the needs of these stakeholders demands an integrated approach. To meet this requirement, Snowfish has developed solutions to help aid therapy interest and uptake by optimizing engagement with three main groups: patients, clinicians, and medical/advocacy organizations on a global basis.
Details